کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5969230 1576178 2014 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
The effects of perioperative β-blockers on mortality in patients undergoing non-cardiac surgery in real world: A meta-analysis of cohort studies
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
The effects of perioperative β-blockers on mortality in patients undergoing non-cardiac surgery in real world: A meta-analysis of cohort studies
چکیده انگلیسی


- We perform a meta-analysis to evaluate perioperative ß-blockers in the real world scenarios.
- We include 8 cohortstudieswith a total of 470,059 participants.
- We find the routine use of ß-blockers does not seem to reduce the risk of death.
- Taking ß- blockers on the day of surgery may increase the mortality.
- These results are limited by the significant heterogeneity across the studies.

BackgroundDespite the fact that recent evidence from meta-analysis of randomized trials indicates an increase in mortality, perioperative treatment with β-blockers is still widely advocated. We therefore performed a meta-analysis of cohort studies to evaluate the effects of perioperative β-blockers on mortality in patients undergoing non-cardiac surgery in the real world scenarios.MethodsWe searched PubMed and Embase from the inception to April 2014 for cohort studies, assessing the effect of perioperative β-blockers on mortality in patients undergoing non-cardiac surgery. Adjusted relative risk (RR) with 95% confidence interval (CI) was pooled using random effect models.ResultsEight cohort studies with a total of 470,059 participants (180,441 patients in the β-blocker group and 289,618 patients in the control group) were included in this meta-analysis. Perioperative β-blockers were not associated with a reduced risk of mortality (RR = 0.88, 95% CI, 0.75 to 1.04), postoperation myocardial infarction (RR = 1.30, 95% CI, 0.76 to 2.23), and postoperation stroke (RR = 1.17, 95% CI, 0.53 to 2.57). However, in subgroup analysis of mortality, taking β-blockers on the day of surgery caused statistically significant increase in mortality of 91% (RR = 1.91, 95% CI, 1.01 to 3.62).ConclusionsIn the real world scenarios, for patients undergoing non-cardiac surgery, the routine use of β-blockers does not seem to reduce the risk of death. Moreover, those who are taking β-blockers on the day of surgery may have an increased risk of postoperative mortality. However, these results should be interpreted with caution because of the significant heterogeneity across the studies.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Cardiology - Volume 176, Issue 3, 20 October 2014, Pages 605-610
نویسندگان
, , , , ,